These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26153151)
1. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma. Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151 [TBL] [Abstract][Full Text] [Related]
2. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma. Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma. Fang R; Huang Y; Xie J; Zhang J; Ji X Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536 [TBL] [Abstract][Full Text] [Related]
4. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma. Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462 [TBL] [Abstract][Full Text] [Related]
5. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma. Foteinou E; Kontos CK; Giotakis AI; Scorilas A Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539 [TBL] [Abstract][Full Text] [Related]
6. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes. Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis. Wang Z; Huang C; Zhang A; Lu C; Liu L Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687 [TBL] [Abstract][Full Text] [Related]
8. [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma]. Hu A; Jin X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):788-92. PubMed ID: 23259291 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene. Shen Z; Zhan G; Deng H; Ren Y; Ye D; Xiao B; Guo J J Laryngol Otol; 2013 Dec; 127(12):1194-202. PubMed ID: 24300127 [TBL] [Abstract][Full Text] [Related]
10. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. Shi Y; Gong HL; Zhou L; Tian J; Wang Y ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features. Erkul E; Yilmaz I; Gungor A; Kurt O; Babayigit MA Laryngoscope; 2017 Feb; 127(2):E62-E66. PubMed ID: 27545281 [TBL] [Abstract][Full Text] [Related]
12. microRNA portraits in human vulvar carcinoma. de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation. Hu Y; Liu H Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):391-9. PubMed ID: 25266939 [TBL] [Abstract][Full Text] [Related]
14. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis. Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression. Li W; Ma H; Sun J Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of microRNA expression profiling in highly metastatic laryngocarcinoma cells. Chen L; Liu S; Li K; Qi J; Liu C; Zong L; Zhang Y; Zhao J; Zhai X; Li J; Kong X; Yang S; Liu M Acta Otolaryngol; 2018 Dec; 138(12):1105-1111. PubMed ID: 30702035 [TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Han L; Jiang B; Wu H; Zhang S; Lu X Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753 [TBL] [Abstract][Full Text] [Related]
18. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488 [TBL] [Abstract][Full Text] [Related]
19. New miRNA expression abnormalities in laryngeal squamous cell carcinoma. Cybula M; Wieteska Ƚ; Józefowicz-Korczyńska M; Karbownik MS; Grzelczyk WL; Szemraj J Cancer Biomark; 2016; 16(4):559-68. PubMed ID: 27002759 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression. Shen N; Huang X; Li J Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]